| 000 | 01680 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516224722.0 | ||
| 264 | 0 | _c20150116 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/jc.2014-2306 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFaje, Alexander T | |
| 245 | 0 | 0 |
_aIpilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cNov 2014 |
||
| 300 |
_a4078-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypopituitarism _xchemically induced |
| 650 | 0 | 4 | _aIpilimumab |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPituitary Gland _xpathology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aSullivan, Ryan | |
| 700 | 1 | _aLawrence, Donald | |
| 700 | 1 | _aTritos, Nicholas A | |
| 700 | 1 | _aFadden, Riley | |
| 700 | 1 | _aKlibanski, Anne | |
| 700 | 1 | _aNachtigall, Lisa | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 99 _gno. 11 _gp. 4078-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2014-2306 _zAvailable from publisher's website |
| 999 |
_c24057017 _d24057017 |
||